How to Buy Springworks Therapeutics Stock
Springworks Therapeutics Inc
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer.
Springworks Therapeutics stock last closed at $45.53, up 3.01% from the previous day, and has increased 95.83% in one year. It has overperformed other stocks in the Biotechnology industry by 1.18 percentage points. Springworks Therapeutics stock is currently +152.94% from its 52-week low of $18.00, and -15.56% from its 52-week high of $53.92.
At the moment, there are 73.79M shares of SWTX outstanding. The market capitalization of SWTX is $3.36B. In the last 24 hours, 898,022 SWTX shares were traded.
How to Buy Springworks Therapeutics Stock
Wondering how to invest in Springworks Therapeutics stock? Here's how.
- Choose where to buy Springworks Therapeutics stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you choose where to buy Springworks Therapeutics stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Pick your payment method and add your details.
- Analyze Springworks Therapeutics stock: The Springworks Therapeutics ticker symbol is SWTX. Is Springworks Therapeutics stock a good investment? Should you buy shares of SWTX? How do SWTX's underlying business fundamentals look? Do top analysts think Springworks Therapeutics is a good buy? Why has SWTX's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if SWTX is a good stock to buy).
- Execute your SWTX purchase: Decide if you will purchase SWTX shares at the current market price or use a limit order to buy SWTX stock at a particular price.
- Get the latest scoop on your SWTX investment: Create a watchlist to important notifications about your position in Springworks Therapeutics shares.
Step 1: Choose where to buy Springworks Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy SWTX shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Technology to Real Estate, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro today.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected the best brokerage, it's time to fill out some personal info so you can invest in SWTX stock today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to open your new brokerage account.
- Send your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've finished signing up on the best stock trading app, your next step is to transfer the money for your investment:
Check out this video walkthrough to see the process of transferring money into your investment account.
Step 4: Analyze Springworks Therapeutics stock
Once you have decided on the best place to buy Springworks Therapeutics stock, it's important to evaluate their stock before you invest, so you actually comprehend the risk and opportunity.
Springworks Therapeutics Metrics
Springworks Therapeutics Overview
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on SWTX's stock page.
Is SWTX stock undervalued or overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge SWTX's fair value.
Using relative valuations ratios:
- SWTX may be undervalued based on its P/B ratio of 5.36x, relative to Biotechnology industry P/B ratio of 5.85x
You can access additional valuation research on SWTX's stock here.
SWTX Financial Summary
Passed Health Checks:
- Total SWTX debt is lower than 5 years ago, relative to shareholder equity.
- SWTX has a low debt to equity ratio of 0.16.
- SWTX has cash burn of 230180000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the SWTX balance sheet.
- There are more short-term assets than long-term liabilities on the SWTX balance sheet.
Failed Health Checks:
- SWTX profit margin has gone down from N/A to -5,968.5% in the past year.
- SWTX has $479.82M in cash and short term investments. This is not enough to cover its annual cash burn of $230.18M.
Is SWTX stock a Buy, Hold, or Sell, according to analysts?
Out of 5 Wall Street analysts who give ratings on SWTX, the consensus analyst rating on SWTX is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Springworks Therapeutics stock forecast page.
SWTX Momentum
How are SWTX Revenues/Earnings doing?
Last year, SWTX revenue was $5.45M. Over the last three year, SWTX's revenue has gone up by -94.52% per year. This was slower than the Biotechnology industry average of 28.56%.
Dive into SWTX's earnings and revenue performance here.
Who is buying/selling SWTX?
Over the past year, executives and large shareholders at SWTX have sold more shares than they have bought.
Bhavesh Ashar, Chief Commercial Officer of SWTX, was the latest SWTX insider to sell. They sold $86,858.88 worth of SWTX stock on Apr 1, 2024.
Learn more about who owns SWTX shares here.
Can I get consistent income from SWTX stock?
No, Springworks Therapeutics doesn't provide an income stream by paying out dividends.
SWTX Social Trading Data
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your SWTX purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally fine. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a specific price limit, place a limit order.
Click the Open Trade button and eToro will place the order.
If you want additional info about buying stocks on eToro, watch the how to video below:
Step 6: Get the latest scoop on your SWTX investment
Now that you own some shares in SWTX, you'll want to keep up with your shares.
Make a watchlist to get alerted to the latest events about your SWTX stock.
SWTX Feed
How to Buy Stock in Springworks Therapeutics
To reiterate, here are the 6 steps for buying Springworks Therapeutics stock:
- Choose where to buy Springworks Therapeutics stock
- Create your brokerage account
- Deposit funds into your investment account
- Analyze Springworks Therapeutics stock
- Execute your SWTX purchase
- Get the latest scoop on your SWTX investment
If you require a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Springworks Therapeutics, add SWTX to your watchlist by clicking the button below.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.